医学
恶心
外科
临床疗效
不利影响
临床试验
预防性抗生素
抗生素
胆囊炎
内科学
胆囊
生物
微生物学
作者
Lin Zhong,Zhengjun Qiu,Guoqing Chen,Junming Xu,Sun Xin,Tonghai Xing,Zhaowen Wang,Junwei Fan,Shuyun Wang,Li Huang,Jinyan Zhang,Zhihai Peng
出处
期刊:Chinese Journal of General Surgery
日期:2012-04-25
卷期号:27 (04): 295-298
标识
DOI:10.3760/cma.j.issn.1007-631x.2012.04.011
摘要
Objective To evaluate the clinical efficiency and safety of cefmetazon in the prevention Department of General Surgery,First People's Hospital,Shanghai Jiaotong University,Shanghai 200080,Chinaand or treatment of infections in general surgery. Methods A multicenter,prospective and open-labeled trial was conducted. In the prevention group,1700 patients were enrolled in clean-infection surgery,cefmetazon was given 1 g iv half an hour before the surgery started,and 1 g iv twice daily after the surgery for 3 days.Clinical response was evaluated in terms of both cure ( disappearance of pre treatment symptoms)and pathogen. In the treatment group,897 patients were diagnosed as peritonitis, cholecystitis and cholangitis,the patients were given cefmetazon 2 g iv twice a day for 7 - 14 days,clinical response and microbiological efficacy were assessed. Results In prophylactic group,1449 patients were finally included.The clinical efficacy was 100% (1449/1449).In the treatment group,a total of 897 patients were enrolled,and 110 patients failed for assessment of clinical efficacy,787 patients were included in the PPS population,the clinical efficacy was 90.7% (714/787); Bacterial eradication rate was 92% (46/50).Adverse reaction rates in prevention group and treatment group were 1.3% (22/1700) and 1.2% (11/897),including mild nausea and vomitting. Conclusions Cefmetazon is effective and safe in prevention and treatment of Postoperative infections in general surgery.
Key words:
Cefmetazole; Antibiotic prophylaxis; Bacterial infections; Treatment outcome
科研通智能强力驱动
Strongly Powered by AbleSci AI